MRM Health, a clinical-stage biopharmaceutical company developing microbiome-based therapeutics for inflammatory diseases and ...

Lindus Health and Quotient Sciences have announced a strategic partnership to enable enhanced patient recruitment and ...

Title21 Health Solutions, a portfolio company specialising in supporting life science regulatory needs, has joined the Blood ...

“The acquisition of Arthrosi allows us to expand our gout pipeline with a highly differentiated new asset. Pozdeutinurad has ...

Topadur Pharma, a clinical-stage biotechnology company specialising in therapies for vascular regeneration, has announced the ...

BICO has announced the appointment of Jesper Hagberg as its new Chief Operations & Digital Officer.

Xmoor Pharma has established a strategic collaboration with the Translational Research Office (TRO) and University College ...

Finnish biotechnology company NADMED has announced the launch of the NADMED Award 2026 in the hope of generating new discoveries in the field of metabolomics.

The scheme could give NHS patients access to new antibiotics as early as 2022 A government scheme to fuel the development of new antibiotics by offering to pay pharmaceutical companies upfront for ...

Survey finds AI to enhance productivity and cut costs in the next 12 months AI is poised to significantly lower pharmaceutical R&D costs through efficient drug discovery, optimised clinical trials, ...

The Christie NHS Foundation Trust has completed a four-month digital transformation project using Netcall’s Liberty Spark to map over 70 care processes across nine patient pathways. The initiative, ...